Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Axsome Thera (AXSM)

Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Axsome Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire - Wed May 27, 6:00AM CDT

NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced...

AXSM : 234.48 (+0.71%)
Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting GlobeNewswire - Tue May 26, 6:00AM CDT

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced...

AXSM : 234.48 (+0.71%)
MarketBeat.com
Axsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer’s Agitation Launch MarketBeat - Tue May 12, 5:08PM CDT

Axsome Therapeutics (NASDAQ:AXSM) executives said the company is preparing for a June launch of AUVELITY in Alzheimer’s disease agitation while continuing to expand its push in major depressive disorder,...

AXSM : 234.48 (+0.71%)
Axsome Therapeutics Recognizes Mental Health Month GlobeNewswire - Thu May 7, 6:00AM CDT

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced...

AXSM : 234.48 (+0.71%)
Axsome Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire - Tue May 5, 6:00AM CDT

NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced...

AXSM : 234.48 (+0.71%)
Axsome: Q1 Earnings Snapshot AP - Mon May 4, 6:14AM CDT

Axsome: Q1 Earnings Snapshot

AXSM : 234.48 (+0.71%)
Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update GlobeNewswire - Mon May 4, 6:00AM CDT

Total 1Q 2026 net product revenue of $191.2 million, representing 57% year-over-year growth AUVELITY ® 1Q 2026 net product sales of $153.2 million, representing 59% year-over-year growth ...

AXSM : 234.48 (+0.71%)
Axsome Therapeutics Reports Its First Quarter Since Doubling Down on Sales Infrastructure Barchart - Sun May 3, 4:00PM CDT

Barchart Research What to Expect from AXSM Earnings AXSM Generated May 1, 2026 Current Price $206.53 EPS Estimate $$-0.85 Consensus Rating Strong Buy Average Move 3.41% Axsome Therapeutics Reports Its...

AXSM : 234.48 (+0.71%)
Axsome Therapeutics Reports Its First Quarter Since Doubling Down on Sales Infrastructure Barchart - Sat May 2, 4:00PM CDT

Barchart Research What to Expect from AXSM Earnings AXSM Generated May 1, 2026 Current Price $206.53 EPS Estimate $$-0.85 Consensus Rating Strong Buy Average Move 3.41% Axsome Therapeutics Reports Its...

AXSM : 234.48 (+0.71%)
Axsome Therapeutics Reports Its First Quarter Since Doubling Down on Sales Infrastructure Barchart - Fri May 1, 4:03PM CDT

Barchart Research What to Expect from AXSM Earnings AXSM Generated May 1, 2026 Current Price $206.53 EPS Estimate $$-0.85 Consensus Rating Strong Buy Average Move 3.41% Axsome Therapeutics Reports Its...

AXSM : 234.48 (+0.71%)

Barchart Exclusives

Why Cathie Wood Is Pounding the Table for $750,000 Bitcoin: A New Generation Loves Crypto to Hedge Against Inflation Barchart - Sat May 30, 2:00PM CDT
The star fund manager believes that the crypto's price can reach $1.25 million per coin. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.